- Clinically isolated syndrome (CIS) and a treatment by glatiramer acetate2014 | Publication without faculty affiliation
- Effect of LPG-endermotherapy on skin changes resulting from long-term treatment with glatiramer acetate +12015 | Second Faculty of Medicine
- Glatiramer acetate and three case reports2016 | Faculty of Medicine in Hradec Králové
- Long-term effectiveness of glatiramer acetate in clinical practice conditions: XPERIENCIA-5 Study2015 | Publication without faculty affiliation
- Lymphocyte populations and their change during five-year glatiramer acetate treatment2018 | Faculty of Medicine in Hradec Králové
- Dlouhodobá účinnost glatiramer acetátu v podmínkách klinické praxe2014 | Third Faculty of Medicine
- Glatiramer acetate - mechanisms of anti-inflammatory and neuroprotective actions2014 | Faculty of Medicine in Hradec Králové
- GALA trial - glatiramer acetate 40 mg three times a week2014 | First Faculty of Medicine
- Interferon β and glatiramer acetate in the treatment of multiple sclerosis; new insights into their activities2014 | Faculty of Medicine in Hradec Králové
- CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate2019 | Faculty of Medicine in Hradec Králové
- Comparative efficacy of first-line natalizumab vs IFN-Beta or glatiramer acetate in relapsing MS2016 | First Faculty of Medicine
- Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups2021 | Faculty of Medicine in Hradec Králové
- Erratum - Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Im-munity in a Group of Women with Multiple Sclerosis (vol 86, pg 334, 2023)2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Comparison of switch to fingolimod and continued treatment with glatiramer acetate or interferon Beta in patients with relapsing multiple sclerosis: Follow-up analysis of the EPOC clinical trial2015 | Publication without faculty affiliation
- Interferon beta-1a vs. glatiramer acetate: changes of innate immunity in a group of women with multiple sclerosis2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Glatiramer acetate and treatment of multiple sclerosis2015 | Faculty of Medicine in Hradec Králové
- Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a2021 | First Faculty of Medicine
- Interferons-β treatment during pregnancy and breast-feeding2020 | Second Faculty of Medicine
- Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis2015 | First Faculty of Medicine
- Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis2015 | First Faculty of Medicine
- Komentář ke studii (Dlouhodobá bezpečnost a snášenlivost glatiramer acetátu v dávce 20 mg v terapii relabující roztroušené sklerózy)2017 | Publication without faculty affiliation
- Multiple sclerosis +12008 | First Faculty of Medicine
- Current therapeutic options for multiple sclerosis2010 | First Faculty of Medicine
- Pharmacological treatment possibilities in clinically isolated syndrome2009 | First Faculty of Medicine
- Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis2019 | First Faculty of Medicine
- Oral BG-12 in Multiple Sclerosis Reply2013 | First Faculty of Medicine
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study2013 | First Faculty of Medicine
- Current treatment options in multiple sclerosis2011 | First Faculty of Medicine